These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32451573)

  • 1. Bisphosphonate Therapy and Tooth Development in Children and Adolescents with Osteogenesis Imperfecta.
    Malmgren B; Tsilingaridis G; Monsef-Johansson N; Qahtani ZHA; Dahllöf G; Åström E
    Calcif Tissue Int; 2020 Aug; 107(2):143-150. PubMed ID: 32451573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Root resorption of primary molars and dental development of premolars in children with Osteogenesis Imperfecta medicated with bisphosphonates, grouped according to age and gender.
    Garcete Delvalle CS; De Nova García MJ; Mourelle Martínez MR
    BMC Oral Health; 2024 Jul; 24(1):857. PubMed ID: 39069613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta.
    Kamoun-Goldrat A; Ginisty D; Le Merrer M
    Eur J Oral Sci; 2008 Jun; 116(3):195-8. PubMed ID: 18471236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment.
    Vuorimies I; Arponen H; Valta H; Tiesalo O; Ekholm M; Ranta H; Evälahti M; Mäkitie O; Waltimo-Sirén J
    Bone; 2017 Jan; 94():29-33. PubMed ID: 27725317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta.
    Del Rio Cantero N; Mourelle Martínez MR; Sagastizabal Cardelús B; De Nova García JM
    Bone; 2024 May; 182():117069. PubMed ID: 38458305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate affects the mandibular cortex of children with osteogenesis imperfecta.
    Apolinário AC; Figueiredo PT; Guimarães AT; Acevedo AC; Castro LC; Paula AP; Paula LM; Melo NS; Leite AF
    J Dent Res; 2015 Mar; 94(3 Suppl):95S-102S. PubMed ID: 25608973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cranial base pathology in pediatric osteogenesis imperfecta patients treated with bisphosphonates.
    Arponen H; Vuorimies I; Haukka J; Valta H; Waltimo-Sirén J; Mäkitie O
    J Neurosurg Pediatr; 2015 Mar; 15(3):313-20. PubMed ID: 25559924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental alterations on panoramic radiographs of patients with osteogenesis imperfecta in relation to clinical diagnosis, severity, and bisphosphonate regimen aspects: a STROBE-compliant case-control study.
    Marçal FF; Ribeiro EM; Costa FWG; Fonteles CSR; Teles GS; de Barros Silva PG; Chaves Junior CM; Ribeiro TR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):621-630. PubMed ID: 31399368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy.
    Sousa T; Bompadre V; White KK
    J Pediatr Orthop; 2014 Jan; 34(1):118-22. PubMed ID: 23863411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate Therapy Increases Trabecular Bone Complexity of Mandibular Condyles in Individuals with Osteogenesis Imperfecta.
    Pantoja LLQ; Lustosa M; Yamaguti PM; Rosa LS; Leite AF; Figueiredo PTS; Castro LC; Acevedo AC
    Calcif Tissue Int; 2022 Mar; 110(3):303-312. PubMed ID: 34677656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
    Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
    Bone; 2016 May; 86():53-7. PubMed ID: 26927310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone density, fractures and the associated factors in iranian children and adolescent with Osteogenesis Imperfecta.
    Mohsenzade P; Amirhakimi A; Honar N; Saki F; Omrani GHR; Dabbaghmanesh M
    BMC Pediatr; 2021 Jan; 21(1):37. PubMed ID: 33446151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
    Zeitlin L; Rauch F; Plotkin H; Glorieux FH
    Pediatrics; 2003 May; 111(5 Pt 1):1030-6. PubMed ID: 12728084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of scoliosis in young children with osteogenesis imperfecta undergoing intravenous bisphosphonate therapy.
    Kashii M; Kanayama S; Kitaoka T; Makino T; Kaito T; Iwasaki M; Kubota T; Yamamoto T; Ozono K; Yoshikawa H
    J Bone Miner Metab; 2019 May; 37(3):545-553. PubMed ID: 30187275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children With Osteogenesis Imperfecta.
    Vuorimies I; Mäyränpää MK; Valta H; Kröger H; Toiviainen-Salo S; Mäkitie O
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1333-1339. PubMed ID: 28323993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment.
    Apolinário AC; Sindeaux R; de Souza Figueiredo PT; Guimarães AT; Acevedo AC; Castro LC; de Paula AP; de Paula LM; de Melo NS; Leite AF
    Dentomaxillofac Radiol; 2016; 45(4):20150400. PubMed ID: 26954289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in Tooth Formation after Early Bisphosphonate Treatment in Children with Osteogenesis Imperfecta.
    Malmgren B; Thesleff I; Dahllöf G; Åström E; Tsilingaridis G
    Calcif Tissue Int; 2021 Aug; 109(2):121-131. PubMed ID: 33743023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
    Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
    J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.